Evidence map›Paper›PMID 28410407›Full record

ArticlePLoS pathogens2017

Bacterial amyloid curli acts as a carrier for DNA to elicit an autoimmune response via TLR2 and TLR9.

Sarah A Tursi, Ernest Y Lee, Nicole J Medeiros, Michael H Lee, Lauren K Nicastro, Bettina Buttaro, Stefania Gallucci, Ronald Paul Wilson, Gerard C L Wong, Çagla Tükel

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 111 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Exploring bet-hedging inmSystems · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Biofilm-associated molecular patterns: BAMPs.Infection and immunity · 2025
    Review
  12. Review
  13. Review
  14. Extracellular DNA-protein interactions.Current opinion in structural biology · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Sarah A TursiDepartment of Microbiology and Immunology, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States of America.
Ernest Y LeeDepartment of Bioengineering, California Nano Systems Institute, University of California, Los Angeles, California, United States of America.ORCID http://orcid.org/0000-0001-5144-2552
Nicole J MedeirosDepartment of Microbiology and Immunology, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States of America.ORCID http://orcid.org/0000-0003-4449-2441
Michael H LeeDepartment of Microbiology and Immunology, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States of America.
Lauren K NicastroDepartment of Microbiology and Immunology, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States of America.
Bettina ButtaroDepartment of Microbiology and Immunology, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States of America.
Stefania GallucciDepartment of Microbiology and Immunology, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States of America.ORCID http://orcid.org/0000-0003-4737-8003
Ronald Paul WilsonDepartment of Microbiology and Immunology, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States of America.
Gerard C L WongDepartment of Bioengineering, California Nano Systems Institute, University of California, Los Angeles, California, United States of America.
Çagla TükelDepartment of Microbiology and Immunology, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States of America.ORCID http://orcid.org/0000-0001-7073-0226
Temple University · USCalifornia NanoSystems Institute · US

Funding

UCLA-Caltech Medical Scientist Training ProgramT32GM008042 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI AJIJOLA, OLUJIMI A, DAWSON, DAVID WAYNE · 1985 to 2023
$29.9M
Systems in Integrative BiologyT32GM008185 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHOU, TOM · 1987 to 2022
$4.6M
Bacterial amyloids: interactions with DNA and pathogenicityR56AI125429 · NIAID · TEMPLE UNIV OF THE COMMONWEALTH · PI TUKEL, CAGLA · 2017 to 2017
$557k
Immune recognition of amyloid/extracellular DNA complexesR21AI132996 · NIAID · TEMPLE UNIV OF THE COMMONWEALTH · PI TUKEL, CAGLA · 2017 to 2018
$429k
Bacterial amyloids break tolerance in lupusR21AI119947 · NIAID · TEMPLE UNIV OF THE COMMONWEALTH · PI GALLUCCI, STEFANIA · 2016 to 2017
$429k
Inflammasome activation by Salmonella typhimurium biofilmsR21AI126133 · NIAID · TEMPLE UNIV OF THE COMMONWEALTH · PI TUKEL, CAGLA · 2016 to 2017
$429k
Glyco-therapeutics for Treating Persistent S. aureus Infections of Skin and Soft TissueR21AI122212 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KASKO, ANDREA MARIE, WONG, GERARD C · 2016 to 2017
$399k
The Role of Bacterial Pathogens in LupusR56AR072115 · NIAMS · TEMPLE UNIV OF THE COMMONWEALTH · PI CARICCHIO, ROBERTO, TUKEL, CAGLA · 2017 to 2017
$396k
NIAID NIH HHS R21 AI119947NIAID NIH HHS R21 AI122212NIAID NIH HHS R21 AI126133NIAID NIH HHS R21 AI132996NIAID NIH HHS R56 AI125429NIAMS NIH HHS R56 AR072115NIGMS NIH HHS T32 GM008042NIGMS NIH HHS T32 GM008185
6 · The paper itself

Abstract

Bacterial biofilms are associated with numerous human infections. The predominant protein expressed in enteric biofilms is the amyloid curli, which forms highly immunogenic complexes with DNA. Infection with curli-expressing bacteria or systemic exposure to purified curli-DNA complexes triggers autoimmunity via the generation of type I interferons (IFNs) and anti-double-stranded DNA antibodies. Here, we show that DNA complexed with amyloid curli powerfully stimulates Toll-like receptor 9 (TLR9) through a two-step mechanism. First, the cross beta-sheet structure of curli is bound by cell-surface Toll-like receptor 2 (TLR2), enabling internalization of the complex into endosomes. After internalization, the curli-DNA immune complex binds strongly to endosomal TLR9, inducing production of type I IFNs. Analysis of wild-type and TLR2-deficient macrophages showed that TLR2 is the major receptor that drives the internalization of curli-DNA complexes. Suppression of TLR2 internalization via endocytosis inhibitors led to a significant decrease in Ifnβ expression. Confocal microscopy analysis confirmed that the TLR2-bound curli was required for shuttling of DNA to endosomal TLR9. Structural analysis using small-angle X-ray scattering revealed that incorporation of DNA into curli fibrils resulted in the formation of ordered curli-DNA immune complexes. Curli organizes parallel, double-stranded DNA rods at an inter-DNA spacing that matches up well with the steric size of TLR9. We also found that production of anti-double-stranded DNA autoantibodies in response to curli-DNA was attenuated in TLR2- and TLR9-deficient mice and in mice deficient in both TLR2 and TLR9 compared to wild-type mice, suggesting that both innate immune receptors are critical for shaping the autoimmune adaptive immune response. We also detected significantly lower levels of interferon-stimulated gene expression in response to purified curli-DNA in TLR2 and TLR9 deficient mice compared to wild-type mice, confirming that TLR2 and TLR9 are required for the induction of type I IFNs. Finally, we showed that curli-DNA complexes, but not cellulose, were responsible elicitation of the immune responses to bacterial biofilms. This study defines the series of events that lead to the severe pro-autoimmune effects of amyloid-expressing bacteria and suggest a mechanism by which amyloid curli acts as a carrier to break immune tolerance to DNA, leading to the activation of TLR9, production of type I IFNs, and subsequent production of autoantibodies.

Indexed as

AutoimmunityAmyloidAnimalsBacterial ProteinsDNA, BacterialHumansInterferon Type IMacrophagesMiceMice, Inbred C57BLSalmonella InfectionsSalmonella typhimuriumToll-Like Receptor 2Toll-Like Receptor 9AmyloidBacterial ProteinsDNA, BacterialInterferon Type IToll-Like Receptor 2Toll-Like Receptor 9

Identifiers

PMID28410407
PMCPMC5406031
OpenAlexW2606357464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.